Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan and Cisplatin in Advanced Esophageal Cancer
NCT00030862Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Oct 2001
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in esophageal cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Oct 2001; status: completed.
02
Drugs
irinotecan
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00030862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030862.